- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03728400
Follow-up of Malnutrition Screening in USINV (DENUTRITION)
March 6, 2023 updated by: Groupe Hospitalier Paris Saint Joseph
Follow-up of Malnutrition Screening in Neurovascular Intensive Care Unit
This aim of the study is to set up a procedure for screening for undernutrition in the neurovascular intensive care unit.
This screening procedure follows a specific work concerning undernutrition in thrombolyzed patients (NCT03303820).
This work was motivated by the fact that, despite a high frequency of undernutrition in the hospital (at least 30% of patients), undernutrition in neurovascular unit is studied very little.
A cohort of thrombolysed patients in 2014 was studied retrospectively.
Patients malnourished at the entrance had a non-significant, less good recovery of their stroke (+ 1 Rankin score point at 3 months in malnourished patients at the entrance).
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
The main objective of this project is to assess, prospectively, the frequency of undernutrition at the entrance to the neurovascular intensive care unit and to evaluate the implementation of the undernutrition screening procedure.
Study Type
Observational
Enrollment (Actual)
66
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France, 75014
- Groupe Hospitalier Paris Saint-Joseph
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
70 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients hospitalized in Neurovascular Intensive care Unit following a stroke
Description
Inclusion Criteria:
- Patient whose age ≥ 70 years
- Patient hospitalized in Neurovascular Intensive care Unit following a stroke (infarction or cerebral hematoma)
- Francophone patient
Exclusion Criteria:
- Patient hospitalized in Neurovascular Intensive care Unit following a transient ischemic attack
- Patient whose age ≤ 70 years
- Patient hospitalized in Neurovascular Intensive care Unit for another reason than neurovascular disease
- Patient opposing the use of his data
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients in neurovascular intensive care
During the patient's hospitalization in neurovascular intensive care unit, the doctor will propose to the patient to take part in this study.
If the patient agree, this search will not change the patient's usual support and will not involve any further review.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
frequency of undernutrition at the entrance
Time Frame: Day 1
|
The primary endpoint is the number of patients who have had an assessment of their nutritional status, that is, for whom undernutrition is detected according to the terms proposed in the undernutrition screening procedure: search for previous quantified weight loss, input BMI, albuminemia.
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Rankin scale
Time Frame: 3 months
|
The Rankin score will be performed in post stroke consultation, 3 months after inclusion.
Rankin scale: 0 no symptoms, 1 No significant disability.
Able to carry out all usual activities, despite some symptoms, 2 Slight disability.
Able to look after own affairs without assistance, but unable to carry out all previous activities, 3 Moderate disability.
Requires some help, but able to walk unassisted, 4 Moderately severe disability.
Unable to attend to own bodily needs without assistance, and unable to walk unassisted, 5 Severe disability.
Requires constant nursing care and attention, bedridden, incontinent
|
3 months
|
|
Recurrence rate of ischemic or haemorrhagic stroke
Time Frame: 3 months
|
The recurrence of stroke will be collected during the post stroke consultation, 3 months after inclusion.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Marie P BRUANDET, MD, Groupe hospitalier Paris saint Joseph
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 29, 2018
Primary Completion (Actual)
August 30, 2019
Study Completion (Anticipated)
December 30, 2023
Study Registration Dates
First Submitted
October 31, 2018
First Submitted That Met QC Criteria
October 31, 2018
First Posted (Actual)
November 2, 2018
Study Record Updates
Last Update Posted (Estimate)
March 7, 2023
Last Update Submitted That Met QC Criteria
March 6, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DENUTRITION USINV
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea